Are current wound classifications valid for predicting prognosis in people treated for limb-threatening diabetic foot ulcers?
Diabetic foot disease in subjects with End-stage renal Disease: A nationwide study over 14 years highlighting an emerging threat.
Survival of patients following first diagnosis of diabetic foot complications: A nationwide 15-year longitudinal analysis.
A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant.
Impact of wound microbiology on limb preservation in patients with diabetic foot infection.
Modifiable factors related to 7-year renal outcomes in subjects with type 2 diabetes and chronic kidney disease stage 3.
Amino acids and wound healing in people with limb-threatening diabetic foot ulcers.
Diabetic Foot Infection presenting systemic inflammatory response syndrome: A unique disorder of systemic reaction from infection of the most distal body.
Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period.
The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: a randomized, double-blind, placebo-controlled pilot trial.
Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes.
A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin.
